96736 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids
Light emitting devices made by bio-fabrication
#4802PHARMACEUTICALLY ACTIVE COMPOUNDS
#4803Microwave-assisted peptide synthesis
#4804Substituted piperazin-2,5-diones and their use as multifunctional bioactive compounds
#4805Binding ligand linked drug delivery conjugates of tubulysins
#4806Peptides and their use
#4807HCV protease inhibitors and uses thereof
#4808PROTEIN-BINDING METHOTREXATE DERIVATIVES, AND MEDICAMENTS CONTAINING THE SAME
#4809INTERLEUKIN-1 RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS OF TREATMENT
#4810Antiviral peptides against influenza virus
#4811PEPTIDES TARGETED TO PROTEIN KINASE C ISOFORMS AND USES THEREOF
#4812Three-dimensional structure of functional material
#4813Peptide vaccines for cancers expressing tumor-associated antigens
#4814Methods of using TGF-β 1 binding compositions
#4815Chelator conjugates
#4816Selective poly-N-substituted glycine antibiotics
#4817PROLINE-RICH PEPTIDES, PHARMACEUTICAL COMPOSITION, USE OF ONE OR MORE PEPTIDES AND METHOD OF TREATMENT
#4818AMIDATED DOPAMINE NEURON STIMULATING PEPTIDES FOR CNS DOPAMINERGIC UPREGULATION
#4819Cytokine receptor peptides, compositions thereof and methods thereof
#4820Synthetic mimics of mammalian cell surface receptors: method and compositions
#4821Peptide inhibitors of c-jun dimerization and uses thereof
#4822Surface-immobilized antimicrobial peptoids
#4823Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
#4824Synthesis of a radiofluorinated peptide using photolabile protecting groups
#4825Peptides directed for diagnosis and treatment of amyloid-associated diseases
#4826Composition for treating cancer and use thereof
#4827Procoagulant peptides
#4828Method for making a ligand-quantum dot conjugate
#4829MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1
#4830Systems and methods for in vivo measurement of interstitial biological activity, processes and/or compositions
#4831PEYER'S PATCH AND/OR M-CELL TARGETING LIGANDS
#4832MYOSIN LIGHT CHAIN KINASE INHIBITORS AND METHODS OF USE
#4833Amphiphilic peptides and hydrogel matrices thereof for bone repair
#4834Tumor Antigens
#4835TDF-related compounds and analogs thereof
#4836RADIOLABELED BBN-RGD HETERODIMERS FOR CANCER TARGETING
#4837Synthesis of fluorescent metal nanoclusters
#4838Substrate-mimetic Akt inhibitor
#4839Production and use of novel peptide-based agents with bispecific antibodies
#4840Targeting of EWS-FLI1 as anti-tumor therapy
#4841Novel Protein Transduction Domains and Uses Therefor
#4842Biocompatible and biodegradable elastomeric polymers
#4843Synthetic regulators of ferritin protein nanocage pores and methods of use thereof
#4844HOMO-DOUBLY LABELED COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES
#4845Novel Isodipeptide
#4846Peptoid compositions and methods of using the same
#4847Method and peptide for regulating cellular activity
#4848Transglutaminase inhibitors and methods of use thereof
#4849DRUG THERAPY FOR CELIAC SPRUE
#4850METHOD FOR FUNCTIONALISING A HYDROPHOBIC SUBSTRATE
#4851Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
#4852Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
#4853Activated collagen scaffold materials and their special fused active restoration factors
#4854Cytotoxic T-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof
#4855Biomolecular recognition of crystal defects
#4856Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same
#4857Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#4858ErbB interface peptidomimetics and methods of use thereof
#4859EPITOPE SEQUENCES
#4860Peptides for targeting apoptotic cells and uses thereof
#4861Elastin digest compositions and methods utilizing same
#4862FUSION PEPTIDE FOR INHIBITING INTERACTION OF NEURONAL NMDA RECEPTOR (NMDAR) AND NMDAR INTERACTING PROTEINS
#4863Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#4864Compositions of GnRH related compounds and processes of preparation
#4865Compositions of peptides and processes of preparation thereof
#4866Prion epitopes and methods of use thereof
#4867Peptide turn mimetics
#4868NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES
#4869Compounds
#4870Mucin hypersecretion inhibitors and methods of use
#4871Self-assembling peptide amphiphiles and related methods for growth factor delivery
#4872Synthetic peptide amide dimers
#4873ANTIPROLIFERATIVE PEPTIDES AND ANTIBODIES FOR THEIR DETECTION
#4874Influenza virus inhibiting peptides
#4875Retrocyclins: antiviral and antimicrobial peptides
#4876Peptide-based compounds
#4877Plasma protein-binding ligands
#4878Reagents and methods for smooth muscle therapies
#4879Selective substrates for matrix metalloproteinases
#4880Printable Materials
#4881Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
#4882Peptides and compositions for inhibiting fungal growth
#4883PEPTIDES AND PEPTIDOMIMETICS HAVING ANTI-PROLIFERATIVE ACTIVITY AND/OR THAT AUGMENT NUCLEIC ACID DAMAGING AGENTS OR TREATMENTS
#4884KDR peptides and vaccines comprising the same
#4885Peptides for modulating innate immunity
#4886Methods and compositions related to internalizing RGD peptides
#4887Method for producing peptide thioester
#4888Identification of Compounds Modifying A Cellular Response
#4889MODULATORS OF PROTEIN PHOSPHATASE 2A AND PP2A METHYL ESTERASE
#4890Antimicrobial peptides
#4891Screening Methods And The Use Of Agents Identified Using The Same
#4892Peptide based inhibition of caPCNA interaction in cancer
#4893Treatment methods using peptides related to amyloid precursor protein
#4894Compounds for control of appetite
#4895Induction of tumor immunity by variants of folate binding protein
#4896Methods and uses for protein breakdown products
#4897Methods For Immuno-Detection Of Epitopes On Molecules And For Detection Of Interactions Of Molecules Via Fluorescent Dyes
#4898Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation
#4899Microwave-assisted peptide synthesis
#4900Tumour-associated peptides binding to MHC-molecules
#4901Novel T-Helper Antigenic Determinant (THD) Peptides
#4902Fluorescent imaging agents
#4903Composition for palladium-mediated cleavage of peptides containing CXC, CXH or CHM sequences
#4904Glycopeptide derivative
#4905Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals
#4906Compositions and methods for promoting wound healing and tissue regeneration
#4907Methods and compositions related to cyclic peptide synthesis
#4908Methods of protecting against apoptosis using lipopeptides
#4909Polypeptide specifically bound to phosphatidylserine and the use thereof
#4910Methods and compositions related to targeting tumors and wounds
#4911Novel peptides
#4912Peptides that increase collagen or hyaluronic acid production
#4913Probe for detection and quantification of inositol-1,4,5-trisphosphate and a method for detecting and quantifying inositol-1,4,5-trisphosphate using the same
#4914Methods and compositions for tumor vaccination and therapy
#4915Mussel bioadhesive
#4916Polymyxin B Analogs for LPS Detoxification
#4917X-RAY-DENSE CONJUGATE
#4918Specific binding sites in collagen for integrins and use thereof
#4919Alpha-fetoprotein peptides
#4920Peptide-based compounds
#4921Lysobactin amides
#4922POLYOXYALKYLENE CHAIN-CONTAINING LIPID DERIVATIVE AND LIPID FILM STRUCTURE CONTAINING SUCH DERIVATIVE
#4923Compounds capable of interacting with a cell-surface fibroblast growth factor receptor
#4924Synthetic mimics of mammalian cell surface receptors: method and compositions
#4925Composition for treating cancer and use thereof
#4926Fullerene-based amino acids
#4927Polypeptide inhibitors of HSP27 kinase and uses therefor
#4928OMI PDZ MODULATORS
#4929Peptide inhibitors of protein kinase C
#4930Methods and compositions for the treatment of gastrointestinal disorders
#4931Peptides that selectively home to heart vasculature and related conjugates and methods
#4932Adsorbent adsorbing antibody against β1 adrenoreceptor
#4933NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY
#4934Thrombopoietic compounds
#4935Peptides and methods for the treatment of inflammatory disease
#4936Methods and compositions for treating cellular proliferative diseases
#4937Diagnostic and therapeutic agents
#4938METHOD OF REDUCING THE EFFECTS OF ABeta AND COMPOSITIONS THEREFORE
#4939Reagents and Methods for Smooth Muscle Therapies
#4940Reagents and methods for smooth muscle therapies
#4941Method of peptide synthesis
#4942Peptide lipid-containing carrier and method for introducing compound into cells using same
#4943Peptide ligands
#4944Methods of constructing and screening diverse expression libraries
#4945Heteroclitic analogs and related methods
#4946Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
#4947METHOD FOR PREPARING LYSOBACTIN DERIVATIVES
#4948Tissue specific prodrugs
#4949Peptide inhibiting angiotensin converting enzyme
#4950Novel Peptides and the Biological Use Thereof
#4951Alzheimer's disease treatment method
#4952Methods and compositions for treating brain diseases
#4953Modular linkers for conjugation of organic substances to substantially inorganic substances and methods of manufacture and use thereof
#4954Self-assembly and mineralization of peptide-amphiphile nanofibers
#4955Library From Toxin Mutants, And Methods Of Using Same
#4956Composition and Method for Increasing Apoptosis in Cancer Cells
#4957Kinase Inhibitors And Uses Thereof
#4958Enzyme substrate comprising a functional dye and associated technology and methods
#4959Peptide purification by means of hard metal ion affinity chromatography
#4960Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
#4961PEPTIDE-BASED ANTIACNE REAGENTS
#4962Peptide inhibitors of protein kinase C gamma for pain management
#4963Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
#4964Method for finding novel peptide immunostimulatory adjuvants, compositions and methods of use
#4965Methods of treatment by administering anti-connexin proteins and mimetics
#4966PEPTIDE-BASED ANTIDANDRUFF REAGENTS
#4967Antagonists of the bradykinin B1 receptor
#4968Pharmaceutical composition comprising cyclic somatostatin analogues
#4969Antagonists of the bradykinin B1 receptor
#4970Artificial protein, method for absolute quantification of proteins and uses thereof
#4971Emulsified composition for dilution and cancer vaccine composition
#4972Immunogenic epitope for immunotherapy
#4973Retro-inverso gonadotropin-releasing hormone peptide and vaccine composition
#4974PAR-2 agonist
#4975Furin inhibitors
#4976CHEMICALLY MODIFIED CYCLIC PEPTIDES CONTAINING CELL ADHESION RECOGNITION (CAR) SEQUENCES AND USES THEREFOR
#4977SCREENING PROTEINASE MODULATORS USING A CHIMERIC PROTEIN AND SKI-I PROPROTEIN CONVERTASE SUBSTRATES AND INHIBITORS
#4978PEPTIDES FOR USE IN CULTURE MEDIA
#4979Immunotherapeutic peptides against neuronal and brain tumors and related methods and compositions
#4980Vaccine composition comprising an antigen and a peptide having adjuvant properties
#4981Methods of screening for compounds that inhibit binding between amyloid-β(Aβ) and FC-γ receptor IIB (FcγRIIb)
#4982Surfactin-Containing Compositions for Controlling Scab Disease in Agricultural Products
#4983αvβ6 peptide ligands and their uses
#4984MN Gene and Protein
#4985Immune-modulating peptide
#4986NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#4987Disulfide trap MHC class I molecules and uses therefor
#4988RTEF-1 variants and the use thereof for inhibition of angiogenesis
#4989Immunogenic peptides and methods of use for treating and preventing cancer
#4990Methods for the use of inhibitors of antigen presentation by MHC class II molecules
#4991Compositions comprising bowman-birk protease inhibitors and variants thereof
#4992Methods for the specific preparation of lysobactin fragments
#4993Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions
#4994Synthetic peptides containing the motif "YWWLXP" as anthrax toxin antidotes
#4995House Dust Mite Allergen
#4996Templates for controlling synthesis of nanoparticles into discrete assemblies
#4997METASTIN DERIVATIVES AND USE THEREOF
#4998Enzyme inhibition
#4999Novel neuroprotective peptide
#5000Peptide tyrosinase inhibitors and uses thereof
#5001HLA-A24-restricted cancer antigen peptides
#5002Albumin Fusion Proteins
#5003SELF ASSEMBLING PEPTIDE SYSTEMS AND METHODS
#5004HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
#5005Methods, systems and reagents for improved immunodetection
#5006CALCIUM BINDING PEPTIDES
#5007Albumin Fusion Proteins
#5008Methods for selective targeting
#5009BRAIN-LOCALIZING CELLS AND USES THEREOF
#5010Amyloid [β] Beta fibrillogenesis-inhibiting peptide
#5011Prosaposin as a neurotrophic factor
#5012Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery
#5013Compositions and methods for counteracting effects of reactive oxygen species and free radicals
#5014Plant-derived elastin binding protein ligands and methods of using the same
#5015PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME
#5016Sustained release of Apo A-I mimetic peptides and methods of treatment
#5017METHOD FOR ISOLATING HEPATITIS C VIRUS PEPTIDES
#5018PIF peptides biologic activities, site of action, and the antibody to detect PIF
#5019Immunogenic compositions and methods
#5020Phenolic binding peptides
#5021Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use
#5022IMMUNOMODULATING OLIGOPEPTIDES
#5023Peptide vaccine for influenza virus
#5024Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof
#5025VACUOLE TARGETING PEPTIDE AND NUCLEIC ACID
#5026Substrate peptide sequences for plague plasminogen activator and uses thereof
#5027USE OF TIGHT JUNCTION ANTAGONISTS TO TREAT INFLAMMATORY BOWEL DISEASE
#5028Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
#5029METHODS AND COMPOSITIONS FOR TREATING CONDITIONS
#5030Human monoclonal antibody specific for lipopolysaccharides (LPS) of the IATS O11 serotype
#5031Peptides of CaV2.2 that inhibit pain
#5032Comparative ligand mapping from MHC class I positive cells
#5033CONOPEPTIDES AND METHODS OF USE
#5034Methods and compositions for the treatment of gastrointestinal disorders
#5035Compounds Binding To P-Selectin
#5036Glycogen synthase kinase-3 inhibitors
#5037Synthetic peptide and peptide conjugates and related tissue coupling methods via transglutaminase enzyme
#5038Transfection complexes
#5039Bi-dentate compounds as kinase inhibitors
#5040Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
#5041Peptides which bind to G protein-coupled receptors
#5042Specific binding agents of human angiopoietin-2
#5043Methods and compositions for identifying a cellular immune response against prostate cancer
#5044Antibacterial peptides and analogues thereof
#5045LPS OR LIPID A BINDING AGENT AND NOVEL PEPTIDE
#5046Cytokine receptor modulators and uses thereof
#5047Antagonists of the bradykinin B1 receptor
#5048Anti-angiogenic peptides and methods of use thereof
#5049Transglutaminase inhibitors and methods of use thereof
#5050Inhibitors of protein kinases and uses thereof
#5051Peptides and chemical compound for inhibition of SHP2 function
#5052Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
#5053Compositions and methods for promoting lipid mobilization in humans
#5054Peptides as cell penetrating carriers
#5055Methods and compositions related to targeting wounds, regenerating tissue, and tumors
#5056Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
#5057Peptides for binding calcium carbonates and methods of use
#5058METHOD FOR EFFECTIVELY MEASURING THE ACTIVITY OF CYTOTOXIC T LYMPHOCYTES IN HUMAN AND OUT-BRED ANIMALS
#5059Novel Polypeptide Ligands For Toll-Like Receptor 2 (TLR2)
#5060Carrier conjugates of gnrh-peptides
#5061METHODS AND COMPOSITIONS FOR PROTEIN PURIFICATION
#5062HLA-BINDING PEPTIDE, PRECURSOR THEREOF, AND DNA FRAGMENT AND RECOMBINANT VECTOR CODING FOR SAID HLA-BINDING PEPTIDE
#5063COSMETIC OR DERMATOLOGICAL PREPARATIONS COMPRISING OLIGOPEPTIDES FOR LIGHTENING THE SKIN OF AGE MARKS AND/OR FOR PREVENTING TANNING OF THE SKIN, IN PARTICULAR TANNING OF THE SKIN CAUSED BY UV RADIATION
#5064Peptides Capable of Functioning as Mimotopes for Hormonal Analytes
#5065Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus
#5066Microwave-assisted peptide synthesis
#5067QUANTIFICATION OF VITELLOGENIN
#5068Assays for preimplantation factor and preimplantation factor peptides
#5069Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells
#5070VIP fragments and methods of use
#5071Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors
#5072PURIFICATION OF IMMUNOGLOBULINS USING AFFINITY CHROMATOGRAPHY AND PEPTIDE LIGANDS
#5073Stabilized bioactive peptides and methods of identification, synthesis, and use
#5074Kahalalide F and Related Compounds
#5075Kahalalide compositions
#5076Peptide-based conditioners and colorants for hair, skin, and nails
#5077Binding compounds, immunogenic compounds and peptidomimetics
#5078Glycogen synthase kinase-3 inhibitors
#5079GIP analog and hybrid polypeptides with selectable properties
#5080PEPTIDE LIGANDS FOR PROSTATE SPECIFIC ANTIGEN
#5081Immunoregulatory compositions
#5082Transdermal delivery peptides and method of use thereof
#5083Assays for preimplantation factor and preimplantation factor peptides
#5084Biochemical method for specific protein labeling
#5085Assays for preimplantation factor and preimplantation factor peptides
#5086Antibacterial amide macrocycles VI
#5087Peptides, derivatives and analogs thereof, and methods of using same
#5088Assays for preimplantation factor and preimplantation factor peptides
#5089Substrates and assays for beta-secretase activity
#5090Hla-Binding Peptide, and Dna Fragment and Recombinant Vector Coding for Said Hla-Binding Peptide
#5091BIOLOGICALLY ACTIVE PEPTIDES
#5092Assays for preimplantation factor and preimplantation factor peptides
#5093Therapeutic and diagnostic peptides
#5094METHOD FOR IDENTIFYING HAIR CONDITIONER-RESISTANT HAIR-BINDING PEPTIDES AND HAIR BENEFIT AGENTS THEREFROM
#5095Peptide aptamers that bind to the rep proteins of ssDNA viruses
#5096PEPTIDE MEDIATED SYNTHESIS OF METALLIC AND MAGNETIC MATERIALS
#5097METHOD FOR PRODUCING INHIBITORS AND INHIBITORS FORMED THEREFROM
#5098Prosaposin as a neurotrophic factor
#5099Antimicrobial peptides
#5100Compounds and methods for inhibiting apoptosis